Tahoe

Drug Discovery · South San Francisco, CA · Founded 2022 · Privately Held (backing)

Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. Tahoe is based in South San Francisco, CA and was founded in 2022. It was valued at $131 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $50 million across 1 recorded round; the latest was a $35 million Series A in Aug 2025.

PMV mark · valuation
$131.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$50.0M
Last round
Early Stage VC (Series A)
Aug 2025

Who backs Tahoe?

12 investors
InvestorType
General CatalystVenture capital
Mubadala Investment CompanyOther
AWS StartupsOther
Wing Venture CapitalVenture capital
Amplify PartnersVenture capital
AIX VenturesVenture capital
Conviction PartnersVenture capital
Camford CapitalVenture capital
Databricks VenturesVenture capital
DHVCVenture capital
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Tahoe investors

12 investors are on record for Tahoe, including General Catalyst, Mubadala Investment Company, AWS Startups and Wing Venture Capital. By type, the record holds 9 venture capital firms. The Series A in Aug 2025 drew 8 investors.

Free account
More of Tahoe with a free account
  • ·The complete investor list: 12 names
  • ·Watch Tahoe: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Tahoe in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View